The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
- Assays
- 1
Filter Results (13)
-
Research Grant, 2018Studying Changes in Glucocerebrosidase Activity in People with Parkinson's Disease
Study Rationale:
A dysfunction of the glucocerebrosidase (GCase) protein increases the risk of Parkinson's disease (PD). Blood cells called monocytes produce large amounts of this protein. The aim of... -
Research Grant, 2018Improving Existing LRRK2 Tests with Novel Reagents
Promising Outcomes of Original Grant:
The goal of our original study was to determine the best conditions for collecting and processing blood cells intended for testing the function of LRRK2, a protein... -
Research Grant, 2018Development of Experimental Setups Using New Antibodies to Detect Alpha-synuclein in Cerebrospinal Fluid
Study Rationale:
Research studies have yet to clearly explain whether alpha-synuclein oligomers -- clumps of protein alpha-synuclein -- in biologicals fluids can be used in clinics as measures of... -
Research Grant, 2018Evaluation and Comparison of Existing Tests for Alpha-synuclein
Study Rationale:
An increase in the levels of alpha-synuclein -- a sticky protein that clumps in the brains of people with Parkinson's disease (PD) -- has been directly linked to an increased risk of... -
Access to Data and Biospecimens, 2018A New Test for Rapid and Ultra-Sensitive Detection of Hallmarks of Parkinson's Disease in Cerebrospinal Fluid
Study Rationale:
The diagnosis and treatment of Parkinson's disease (PD) would be aided by the availability of direct and highly sensitive tests for the abnormal clumps of protein alpha-synuclein... -
Oligomeric & pS129 Assay LEAPS, 2017Exploring the Use of Alpha-synuclein Assays for Translational Biomarkers and Pharmaceutical Intervention Trials
Study Rationale:
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. The biggest roadblock facing the development of disease-modifying therapies is...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.